During the past decade, Hospital del Mar Servicio de Neurología conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital del Mar Servicio de Neurología" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Hospital del Mar Servicio de Neurología" in a lesser frequency.

Most popular intervention types in "Hospital del Mar Servicio de Neurología" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (5 trials), "Placebo" (4 trials), "Ocrelizumab" (3 trials), "3APS" (1 trials) and "MD1003 100mg capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital del Mar Servicio de Neurología" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Hospital del Mar Servicio de Neurología". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital del Mar Servicio de Neurología, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital del Mar Servicio de Neurología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".